{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T08:33:25Z","timestamp":1770626005804,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1038\/s41440-023-01253-7","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T08:06:14Z","timestamp":1680163574000},"page":"1471-1477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hypertension management before and under the COVID-19 pandemic: lessons and future directions"],"prefix":"10.1038","volume":"46","author":[{"given":"Yoichi","family":"Nozato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"Collaboration NCDRF","year":"2021","unstructured":"Collaboration NCDRF Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 2017;390:2549\u201358.","journal-title":"Lancet"},{"key":"1253_CR3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res: Off J Jpn Soc Hypertens. 2019;42:1235\u2013481.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41440-018-0111-8","volume":"41","author":"K Node","year":"2018","unstructured":"Node K, Kishi T, Tanaka A, Itoh H, Rakugi H, Ohya Y, et al. The Japanese Society of Hypertension-Digest of plan for the future. Hypertens Res: Off J Jpn Soc Hypertens. 2018;41:989\u201390.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1161\/CIR.0000000000000803","volume":"142","author":"D Shimbo","year":"2020","unstructured":"Shimbo D, Artinian NT, Basile JN, Krakoff LR, Margolis KL, Rakotz MK, et al. Self-measured blood pressure monitoring at home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation 2020;142:e42\u2013e63.","journal-title":"Circulation"},{"key":"1253_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270\u20133.","journal-title":"Nature"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","volume":"38","author":"M Esler","year":"2020","unstructured":"Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020;38:781\u20132.","journal-title":"J Hypertens"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41440-021-00641-1","volume":"44","author":"H Kai","year":"2021","unstructured":"Kai H, Kai M, Niiyama H, Okina N, Sasaki M, Maeda T, et al. Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies. Hypertens Res: Off J Jpn Soc Hypertens. 2021;44:955\u201368.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1253_CR9","doi-asserted-by":"publisher","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","volume":"4","author":"R Baral","year":"2021","unstructured":"Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, et al. Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis. JAMA Netw Open. 2021;4:e213594.","journal-title":"JAMA Netw Open"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/ajh\/hpac001","volume":"35","author":"J Yin","year":"2022","unstructured":"Yin J, Wang C, Song X, Li X, Miao M. Effects of Renin-Angiotensin system inhibitors on mortality and disease severity of COVID-19 patients: a meta-analysis of randomized controlled trials. Am J Hypertens. 2022;35:462\u20139.","journal-title":"Am J Hypertens"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ehjcvp\/pvaa138","volume":"8","author":"MMY Lee","year":"2022","unstructured":"Lee MMY, Docherty KF, Sattar N, Mehta N, Kalra A, Nowacki AS, et al. Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022;8:165\u201378.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"e026143","DOI":"10.1161\/JAHA.122.026143","volume":"11","author":"SR Gnanenthiran","year":"2022","unstructured":"Gnanenthiran SR, Borghi C, Burger D, Caramelli B, Charchar F, Chirinos JA, et al. Renin-Angiotensin system inhibitors in patients With COVID-19: A meta-analysis of randomized controlled trials led by the International Society of Hypertension. J Am Heart Assoc. 2022;11:e026143.","journal-title":"J Am Heart Assoc"},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.120.047022","volume":"141","author":"FH Messerli","year":"2020","unstructured":"Messerli FH, Siontis GCM, Rexhaj E. COVID-19 and Renin Angiotensin blockers: current evidence and recommendations. Circulation 2020;141:2042\u20134.","journal-title":"Circulation"},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41440-020-0515-0","volume":"43","author":"S Shibata","year":"2020","unstructured":"Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, et al. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens Res: Off J Jpn Soc Hypertens. 2020;43:1028\u201346.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/jch.13917","volume":"22","author":"K Kario","year":"2020","unstructured":"Kario K, Morisawa Y, Sukonthasarn A, Turana Y, Chia YC, Park S, et al. COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network. J Clin Hypertens. 2020;22:1109\u201319.","journal-title":"J Clin Hypertens"},{"key":"1253_CR16","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/CIRCRESAHA.121.318054","volume":"128","author":"C Savoia","year":"2021","unstructured":"Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: Current views and perspectives. Circ Res. 2021;128:1062\u201379.","journal-title":"Circ Res"},{"key":"1253_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40292-022-00506-9","volume":"29","author":"G Gallo","year":"2022","unstructured":"Gallo G, Calvez V, Savoia C. Hypertension and COVID-19: Current evidence and perspectives. High Blood Press Cardiovasc Prev. 2022;29:115\u201323.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"1253_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41440-022-00978-1","volume":"45","author":"O Yamazaki","year":"2022","unstructured":"Yamazaki O, Shibata S. Severe COVID-19 and preexisting hypertension: a matter of age? Hypertens Res: Off J Jpn Soc Hypertens. 2022;45:1523\u20135.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41440-022-00893-5","volume":"45","author":"E McFarlane","year":"2022","unstructured":"McFarlane E, Linschoten M, Asselbergs FW, Lacy PS, Jedrzejewski D, Williams B, et al. The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19. Hypertens Res: Off J Jpn Soc Hypertens. 2022;45:834\u201345.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"1253_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583\u201390.","journal-title":"Nat Med"},{"key":"1253_CR21","doi-asserted-by":"publisher","first-page":"e0250815","DOI":"10.1371\/journal.pone.0250815","volume":"16","author":"G Chen","year":"2021","unstructured":"Chen G, Li X, Gong Z, Xia H, Wang Y, Wang X, et al. Hypertension as a sequela in patients of SARS-CoV-2 infection. PLoS One. 2021;16:e0250815.","journal-title":"PLoS One"},{"key":"1253_CR22","doi-asserted-by":"publisher","first-page":"e13859","DOI":"10.1111\/eci.13859","volume":"52","author":"G Mavraganis","year":"2022","unstructured":"Mavraganis G, Dimopoulou MA, Delialis D, Bampatsias D, Patras R, Sianis A, et al. Clinical implications of vascular dysfunction in acute and convalescent COVID-19: A systematic review. Eur J Clin Invest. 2022;52:e13859.","journal-title":"Eur J Clin Invest"},{"key":"1253_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/00033197211053903","volume":"73","author":"M Akpek","year":"2022","unstructured":"Akpek M. Does COVID-19 cause hypertension? Angiology 2022;73:682\u20137.","journal-title":"Angiology"},{"key":"1253_CR24","doi-asserted-by":"crossref","unstructured":"Wrona M, Skrypnik D. New-onset diabetes mellitus, hypertension, Dyslipidaemia as Sequelae of COVID-19 infection-systematic review. Int J Environ Res Public Health. 2022;19:13280.","DOI":"10.3390\/ijerph192013280"},{"key":"1253_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2020.10.055","volume":"77","author":"RK Wadhera","year":"2021","unstructured":"Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol. 2021;77:159\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR26","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","volume":"75","author":"S Garcia","year":"2020","unstructured":"Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2871\u20132.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jacc.2020.05.038","volume":"76","author":"AS Bhatt","year":"2020","unstructured":"Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol. 2020;76:280\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1056\/NEJMc2015630","volume":"383","author":"MD Solomon","year":"2020","unstructured":"Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, et al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N. Engl J Med. 2020;383:691\u20133.","journal-title":"N. Engl J Med"},{"key":"1253_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/08037051.2022.2060182","volume":"31","author":"T Weber","year":"2022","unstructured":"Weber T, Amar J, de Backer T, Burkard T, van der Giet M, Gosse P, et al. Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension. Blood Press. 2022;31:71\u20139.","journal-title":"Blood Press"},{"key":"1253_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2020.10.054","volume":"77","author":"AJ Einstein","year":"2021","unstructured":"Einstein AJ, Shaw LJ, Hirschfeld C, Williams MC, Villines TC, Better N, et al. International impact of COVID-19 on the diagnosis of heart disease. J Am Coll Cardiol. 2021;77:173\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"1253_CR31","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","volume":"69","author":"ME Czeisler","year":"2020","unstructured":"Czeisler ME, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, et al. Delay or avoidance of medical care because of COVID-19-related concerns - United States, June 2020. MMWR Morb Mortal Wkly. Rep. 2020;69:1250\u20137.","journal-title":"MMWR Morb Mortal Wkly. Rep"},{"key":"1253_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.121.057075","volume":"145","author":"LJ Laffin","year":"2022","unstructured":"Laffin LJ, Kaufman HW, Chen Z, Niles JK, Arellano AR, Bare LA, et al. Rise in blood pressure observed among US adults during the COVID-19 pandemic. Circulation 2022;145:235\u20137.","journal-title":"Circulation"},{"key":"1253_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/d41586-020-02006-z","volume":"583","author":"C Wenham","year":"2020","unstructured":"Wenham C, Smith J, Davies SE, Feng H, Grepin KA, Harman S, et al. Women are most affected by pandemics - lessons from past outbreaks. Nature 2020;583:194\u20138.","journal-title":"Nature"},{"key":"1253_CR34","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1253\/circj.CJ-11-1510","volume":"76","author":"K Kario","year":"2012","unstructured":"Kario K. Disaster hypertension - its characteristics, mechanism, and management. Circ J 2012;76:553\u201362.","journal-title":"Circ J"},{"key":"1253_CR35","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/HYPERTENSIONAHA.116.07499","volume":"68","author":"T Ohira","year":"2016","unstructured":"Ohira T, Hosoya M, Yasumura S, Satoh H, Suzuki H, Sakai A, et al. Evacuation and risk of hypertension after the great east japan earthquake: The Fukushima Health Management Survey. Hypertension 2016;68:558\u201364.","journal-title":"Hypertension"},{"key":"1253_CR36","doi-asserted-by":"publisher","first-page":"e2021476","DOI":"10.1001\/jamanetworkopen.2020.21476","volume":"3","author":"GC Alexander","year":"2020","unstructured":"Alexander GC, Tajanlangit M, Heyward J, Mansour O, Qato DM, Stafford RS. Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3:e2021476.","journal-title":"JAMA Netw Open"},{"key":"1253_CR37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/HJH.0000000000003205","volume":"40","author":"NA Khan","year":"2022","unstructured":"Khan NA, Stergiou GS, Omboni S, Kario K, Renna N, Chapman N, et al. Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2022;40:1435\u201348.","journal-title":"J Hypertens"},{"key":"1253_CR38","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.120.15873","volume":"76","author":"S Omboni","year":"2020","unstructured":"Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension 2020;76:1368\u201383.","journal-title":"Hypertension"},{"key":"1253_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hpja.387","volume":"32","author":"E Kemp","year":"2021","unstructured":"Kemp E, Trigg J, Beatty L, Christensen C, Dhillon HM, Maeder A, et al. Health literacy, digital health literacy and the implementation of digital health technologies in cancer care: the need for a strategic approach. Health Promot J Aust. 2021;32:104\u201314.","journal-title":"Health Promot J Aust"},{"key":"1253_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/HJH.0b013e32835ca8dd","volume":"31","author":"S Omboni","year":"2013","unstructured":"Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost-effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31:455\u201367. discussion 67-8","journal-title":"J Hypertens"},{"key":"1253_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jash.2014.12.001","volume":"9","author":"N Kumar","year":"2015","unstructured":"Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015;9:130\u20136.","journal-title":"J Am Soc Hypertens"},{"key":"1253_CR42","doi-asserted-by":"publisher","first-page":"e060376","DOI":"10.1136\/bmjopen-2021-060376","volume":"12","author":"L Zhu","year":"2022","unstructured":"Zhu L, Li D, Jiang XL, Jia Y, Liu Y, Li F, et al. Effects of telemedicine interventions on essential hypertension: a protocol for a systematic review and meta-analysis. BMJ Open. 2022;12:e060376.","journal-title":"BMJ Open"},{"key":"1253_CR43","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1093\/eurheartj\/ehab559","volume":"42","author":"K Kario","year":"2021","unstructured":"Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021;42:4111\u201322.","journal-title":"Eur Heart J"},{"key":"1253_CR44","doi-asserted-by":"publisher","first-page":"e202165","DOI":"10.1001\/jamanetworkopen.2020.2165","volume":"3","author":"RW Treskes","year":"2020","unstructured":"Treskes RW, van Winden LAM, van Keulen N, van der Velde ET, Beeres S, Atsma DE, et al. Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial. JAMA Netw Open. 2020;3:e202165.","journal-title":"JAMA Netw Open"},{"key":"1253_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5455\/aim.2019.27.263-267","volume":"27","author":"A Jamshidnezhad","year":"2019","unstructured":"Jamshidnezhad A, Kabootarizadeh L, Hoseini SM. The effects of smartphone applications on patients self-care with hypertension: a systematic review study. Acta Inf Med. 2019;27:263\u20137.","journal-title":"Acta Inf Med"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01253-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01253-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01253-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T23:06:32Z","timestamp":1685919992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01253-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01253-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"16 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}